Abstract
We tested anti-tumor activities of macrophages treated with a neutral polysaccharide, schizophyllan (SPG), against syngeneic and allogeneic tumor cell lines. SPG was a macrophage stimulant which was not mitogenic to lymphocytes. That made a sharp contrast with the data that Corynebacterium parvum, BCG, and muramyl dipeptide (MDF) were macrophage stimulants which had lymphocyte-activating properties. Treatment of SPG-treated PEC with Thy12 monoclonal antibody and guinea pig complement did not affect the capabilities of tumor-cell-growth suppression by the treated PEC. Thus, the effector cells were peritoneal adherent cells (macrophages morphologically) and effector-to-target contact seemed to be necessary for effective tumor-cell-growth inhibition, although contradictory data exist for this. Murine peritoneal adherent cells harvested 4 days after a single IP injection of SPG at a dose of 100 mg/kg body weight of mouse showed the most prominent cytostatic and cytotoxic activities against syngeneic and allogeneic tumor cells. The distribution of anti-tumor activity in macrophages of various sizes followed the same pattern as macrophages treated with C. Parvum, i.e., larger macrophages showed more remarkable anti-tumor activity. Crude nonadherent peritoneal cells incubated with SPG at a concentration of 10 μg/ml, 100 μg/ml, or 1 mg/ml did not secrete lymphokine that rendered macrophages cytotoxic, while ConA-treated nonadherent cells did so. Furthermore, spleen cells treated with SPG in vivo did not secrete macrophage-activating lymphokine in the presence of SPG. On the other hand, addition of 1 mg/ml of SPG-treated peritoneal adherent cells and bone-marrow-derived macrophages in vitro rendered them cytotoxic to a moderate degree. This implies that SPG may activate macrophages directly, allowing them to become cytotoxic in the peritoneal cavity. Lastly, SPG could induce production of II-1-like factor to a moderate degree. SPG, whose molecular structure is well elucidated, will provide us with a strong tool to analyze the mechanism of macrophage activation both in vitro and in vivo.
Keywords: Tumor Cell Line, Dipeptide, Spleen Cell, Moderate Degree, Macrophage Activation
Abbreviations
- PEC
peritoneal exudate cells
- SPG
schizophyllan
- LPS
lipopolysaccharide
- Con A
concanavalin A
- CGN
carrageenan
- B. M.
bone marrow
- FCS
fetal calf serum
- BCG
bacille Calmétte Guérin
- Il-1
interleukin 1
- PPD
pure protein derivatives
- MDP
muramyl dipeptide
- C. parvum
Corynebacerium parvum
Footnotes
Dr. Sugawara is a Research Fellow of the Alberta Heritage Foundation for Medical Research
Dr. Lee is a Research Associate of the National Cancer Institute of Canada
References
- 1.Adams DO, Johnson WJ, Marino PA. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity. Fed Proc. 1982;41:2212. [PubMed] [Google Scholar]
- 2.Alexander P, Evans R. Endotoxins and double-stranded RNA render macrophages cytotoxic. Nature. 1971;232:76. doi: 10.1038/newbio232076a0. [DOI] [PubMed] [Google Scholar]
- 3.Allison AC, Harington JS, Birbeck M. An examination of the cytotoxic effects of silica on macrophages. J Exp Med. 1966;124:141. doi: 10.1084/jem.124.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Azuma I, Taniyama T, Sugimura K, Aladin AA, Yamamura Y. Mitogenic activity of the cell walls of mycobacteria, Nocardia, Corynebacteria and anaerobic coryneforms. Jpn J Microbiol. 1976;20:263. doi: 10.1111/j.1348-0421.1976.tb00987.x. [DOI] [PubMed] [Google Scholar]
- 5.Begemann H, Rastetter J. Atlas der klinischen hämatologie. Berlin Heidelberg New York: Springer; 1978. Bildteil; p. 46. [Google Scholar]
- 6.Catanzaro PJ, Schwartz HJ, Graham RC. Spectrum and possible mechanisms of carrageenan cytotoxicity. Am J Pathol. 1971;64:387. [PMC free article] [PubMed] [Google Scholar]
- 7.Chapes SK, Haskill S. Role of Corynebacterium parvum in the activation of peritoneal macrophages. I. Association between intracellular C. parvum and cytotoxic macrophages. Cell Immunol. 1982;70:65. doi: 10.1016/0008-8749(82)90133-2. [DOI] [PubMed] [Google Scholar]
- 8.Doe WF, Henson PM. Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells. J. Exp Med. 1978;149:544. doi: 10.1084/jem.148.2.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Godal T, Rees RJW, Lamvik JO. Lymphocyte-mediated identification of blood-derived macrophage function in vitro; inhibition of growth of intracellular mycobacteria with lymphocytes. Clin Exp Immunol. 1970;8:625. [PMC free article] [PubMed] [Google Scholar]
- 10.Kikuchi M, Iwano K, Numazaki Y. Effect of schizophyllan on immune functions and its anti-tumor activity. Int J Immunopharmacol. 1980;2:173. [Google Scholar]
- 11.Komatsu N, Okuba S, Kikumoto S, Saito G, Sakai S. Host-mediated antitumor action of Schizophyllan, a glucan produced by Schizophyllum commune. Gan. 1969;60:137. [PubMed] [Google Scholar]
- 12.Kripke ML, Pudman MB, Fidler IJ. Production of specific macrophage activating factor by lymphocytes from tumor-bearing mice. Cell Immunol. 1977;130:341. doi: 10.1016/0008-8749(77)90077-6. [DOI] [PubMed] [Google Scholar]
- 13.Lee KC, Berry D. Functional heterogeneity in macrophages activated by Corynebacterium parvum: Characterization of subpopulations with different activities in promoting immune responses and suppressing tumor growth. J Immunol. 1977;118:1530. [PubMed] [Google Scholar]
- 14.Lee KC, Kay J, Wong M. Separation of functionally distinct subpopulations of Corynebacterium parvum-activated macrophages with predominantly stimulatory or suppressive effect on the cell-mediated cytotoxic T cell response. Cell Immunol. 1979;42:28. doi: 10.1016/0008-8749(79)90218-1. [DOI] [PubMed] [Google Scholar]
- 15.Lee KC, Singh B, Barton MA, Procyshyn A, Wong M. A simple reliable method for studying antigen-specific murine T cell proliferation. J Immunol Methods. 1979;25:159. doi: 10.1016/0022-1759(79)90051-6. [DOI] [PubMed] [Google Scholar]
- 16.Lee KC, Wong M, McIntyre D. Characterization of macrophage subpopulations responsive to activation by endotoxin and lymphokines. J Immunol. 1981;126:2474. [PubMed] [Google Scholar]
- 17.Leclerc C, Chedid L. Lymphokines 7. Paris San Diego San Francisco Sao Paulo Sydney Tokyo Toronto: Academic Press; 1982. Macrophage activation by synthetic muramyl peptides; p. 1. [Google Scholar]
- 18.LeMevel BP, Oldham RK, Wells SA, Herberman RB. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assay: kinetics of incorporation and toxicity. J Natl Cancer Inst. 1973;51:1511. doi: 10.1093/jnci/51.5.1551. [DOI] [PubMed] [Google Scholar]
- 19.Lohmann-Mattes ML, Lang L, Sun DM, Kniep E, Kickhofen B. Lymphokines 3. New York London Toronto Sydney San Francisco: Academic Press; 1981. Macrophage activation to cytotoxicity by the macrophage cytotoxicity (activating) factor (MCF, MAF) p. 365. [Google Scholar]
- 20.Metzger Z, Moore RN, Hoffeld JT, Oppenheim JJ. Heterogeneity of mononuclear phagocytes. London New York Toronto Sydney San Francisco: Academic Press; 1981. A fibroblast derived factor activates macrophages to produce hydrogen peroxide in vitro; p. 432. [Google Scholar]
- 21.Miller RG, Phillips RA. Separation of cells by velocity sedimentation. J Cell Physiol. 1969;73:191. doi: 10.1002/jcp.1040730305. [DOI] [PubMed] [Google Scholar]
- 22.Mitani M, Ariga T, Matsuo T, Asano T, Saito G. Anti-tumor effect of Schizophyllan, an immunomodulator, on syngeneic tumors. Int J Immunopharmacol. 1980;2:174. [Google Scholar]
- 23.Mizel SB. Manual of macrophage methodology. New York Basel: Marcel Dekker Inc.; 1981. Production and quantitation of lymphocyte activating factor (Interleukin I) p. 407. [Google Scholar]
- 24.Mizuhira V, Shiihashi M, Shibuya K, Amamiya K, Hase T. The fate of 3H-SPG administered to sarcoma-180 grafted mice. Electron Microscopy. 1980;2:382. [Google Scholar]
- 25.Mizuhira V, Amamiya K, Hase T. Anti-tumor activity of 3H-SPG in tumor-grafted animals-biological response and attitude of local macrophages in the tumor. J Clin Electron Microscopy. 1981;14:5. [Google Scholar]
- 26.Philippeaux MM, Mauel J. Heterogeneity of mononuclear phagocytes. London New York Toronto Sydney San Francisco: Academic Press; 1981. Macrophage toxicity for target cells; p. 507. [Google Scholar]
- 27.Piessens WF, Churchill WH, David FR. Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells. J Immunol. 1975;114:293. [PubMed] [Google Scholar]
- 28.Ruco LP, Meltzer MS, Leonard EJ, Tomisawa S. Biochemistry and function of phagocytes. New York London: Plenum Press; 1982. Macrophage activation for tumor cytotoxicity: reactivity of peritoneal and bone marrow macrophages; p. 85. [DOI] [PubMed] [Google Scholar]
- 29.Sugawara I, Ishizaka S, Möller G. Carrageenans, highly sulfated polysaccharides and macrophage-toxic agents. Newly found human T cell mitogens. Immunobiology. 1982;163:527. doi: 10.1016/S0171-2985(82)80066-1. [DOI] [PubMed] [Google Scholar]
- 30.Sugawara I, Ishizaka S. Polysaccharides with sulfate groups are human T-cell mitogens and murine polyclonal B-cell activators (PBAs). I. Fucoidan and heparin. Cell Immunol. 1982;74:162. doi: 10.1016/0008-8749(82)90016-8. [DOI] [PubMed] [Google Scholar]
- 31.Suzuki M, Arika T, Amamiya K, Fujiwara M. Cooperative role of T lymphocytes and macrophages in anti-tumor activity of mice pretreated with Schizophyllan (SPG) Jpn J Exp Med. 1982;52:59. [PubMed] [Google Scholar]
- 32.Woodruff MFA, Warner NL. Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice. J Natl Cancer Inst. 1977;58:111. doi: 10.1093/jnci/58.1.11. [DOI] [PubMed] [Google Scholar]
- 33.Yamamoto T, Yamashita T, Tsubura E. Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan. Invas Metas. 1981;1:71. [PubMed] [Google Scholar]